
Hims & Hers International Revenue Surges 969% Amid Major U.S. Weight Loss Pivot
Hims & Hers Health, Inc.Description
What this story covers
Hims & Hers reported 2.6 million subscribers and a 969% surge in international revenue. However, a strategic shift away from compounded GLP-1 drugs following FDA scrutiny led to a $92.1 million quarterly loss and tightened gross margins.
Story snapshot
CompanyHims & Hers Health, Inc.
TickerHIMS
VariantStandard detailed
Duration12:34
Filing type10-Q
PeriodQ4 2026
IndustryHealthcare & Pharmaceuticals
Accession0001773751-26-000076
Sources1
Full Story Script
Content not available for this story.